Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $15.6150 (-8.52%) ($15.6150 - $15.6150) on Mon. Jun. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.76% (three month average) | RSI | 38 | Latest Price | $15.6150(-8.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.38% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-7%) IGOV(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.38% (StdDev 4.76%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.53 | 5 Day Moving Average | $16.67(-6.33%) | 10 Day Moving Average | $16.43(-4.96%) | 20 Day Moving Average | $16.53(-5.54%) | To recent high | -9.4% | To recent low | 64.5% | Market Cap | $2.755b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |